FDA Approves First Generic Albuterol Inhaler FDA Approves First Generic Albuterol Inhaler

The FDA has approved the first albuterol inhaler for prevention of bronchospasm in patients aged 4 years and older. Specifically, these are patients with reversible obstructive airway disease or exercise-induced bronchospasm.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Source Type: news